BRIUMVI vs TERIFLUNOMIDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. BRIUMVI and TERIFLUNOMIDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BRIUMVI	TERIFLUNOMIDE
Rating	New	56/100
Pharmacy pays	—	~$16.32 /30
Type	RX	RX
Active ingredient	UBLITUXIMAB-XIIY	TERIFLUNOMIDE
Manufacturer	Tg Therapeutics, Inc	Teva
Dosage forms	Injectable	Tablet
Drug class	—	Pyrimidine Synthesis Inhibitor
Boxed warning	None	Boxed warning
Treats	Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis	Relapsing-Remitting Multiple Sclerosis

briumvi teriflunomide

Rating

New

56/100

Pharmacy pays

—

~$16.32 /30

Type

Active ingredient

UBLITUXIMAB-XIIY

TERIFLUNOMIDE

Manufacturer

Tg Therapeutics, Inc

Teva

Dosage forms

Injectable

Tablet

Drug class

—

Pyrimidine Synthesis Inhibitor

Boxed warning

None

Boxed warning

Treats

Demyelinating Diseases, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

What is the difference between Briumvi and Teriflunomide?

Briumvi contains Ublituximab-Xiiy, while Teriflunomide contains Teriflunomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.